Stocks Making Significant Moves in Premarket Trading: AstraZeneca, PepsiCo, Salesforce, Levi Strauss, and More

AstraZeneca's shares fell 8% after its heart disease drug, Wainua, did not meet targets in a late-stage clinical trial, raising concerns about the company's pipeline. PepsiCo reported mixed second-quarter results, with adjusted earnings of $2.20 per share falling short of the $2.21 expected by analysts, although revenue of $24.18 billion exceeded estimates. This led to a 1% drop in its stock.

Salesforce's stock decreased by 4% following a downgrade from KeyBanc, which cited a lack of evidence for future growth based on market checks. Stellantis also saw a 2% decline after a downgrade from J.P. Morgan, with analysts suggesting a lengthy turnaround period.

Levi Strauss dropped 4% after issuing disappointing third-quarter guidance, expecting earnings per share between 34 and 36 cents, below the 38 cents forecasted by analysts, despite beating second-quarter expectations. In contrast, AZZ's shares rose 6% after reporting earnings per share of $1.85, surpassing the $1.69 consensus estimate, and revenue of $448.5 million also exceeded expectations.

Cerebras Systems' stock increased nearly 7% following news of a major European expansion, planning to enhance its data center capacity significantly by 2027. Costco's shares fell nearly 2% after reporting a slowdown in comparable sales growth for June, with an 8.8% year-over-year increase compared to 12.5% in May

Stocks in this article

Company Price Change Change % AI
Stellantis STLA.US 3.34 -0.20 -5.65% Sell
AZZ Inc AZZ.US 117.37 -5.63 -4.58% Sell
Levi Strauss & Co LEVI.US 22.76 -0.77 -3.27% Hold
Salesforce CRM.US 180.62 -2.69 -1.47% Buy
PepsiCo PEP.US 140.54 +1.54 +1.11% Buy
Costco COST.US 1,102.15 +8.32 +0.76% Buy
AstraZeneca AZN.US 174.35 -1.06 -0.60% Hold

StockGuide AI model context

AstraZeneca · Hold · Risk: 65/100 · Potential: 61/100 · 2026-11-22

AZZ Inc · Sell · Risk: 70/100 · Potential: 35/100 · 2026-11-21

Costco · Buy · Risk: 32/100 · Potential: 74/100 · 2026-11-22

Levi Strauss & Co · Hold · Risk: 60/100 · Potential: 62/100 · 2026-11-22

PepsiCo · Buy · Risk: 59/100 · Potential: 60/100 · 2026-11-21

More business news